CDZ173

CDZ173 · Pharming Technologies B.V.

Drug timelines are a Plus or Pro feature.

3 regulatory and trial events tracked for CDZ173, covering 2019-10-18 to 2026-03-30. Get the full timeline:

Most recent: Clinical Trial Update: Extension to the Study of Efficacy of CDZ173 in Patients With APDS/PASLI [Phase 2, Phase 3]